There is a continuous, steady climb from 2005.

It’s consumption and investment. But primarily, it’s about consumption.

The prescription-drug plans were able to negotiate discounts and rebates that came in larger than we thought, and this has helped mitigate what drug spending would have been.

The prescription drug plans were able to negotiate discounts and rebates that came in larger than we thought, and this has helped mitigate what drug spending would have been. It doesn’t mean drug spending won’t...